Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 11, 2008, Pages 4872-4880

  Yu, Alice L ^a   Fuchshofer, Rudolf ^b   Kampik, Anselm ^a   Welge Lüssen, Ulrich ^a,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; BETA GALACTOSIDASE; BIMATOPROST; FIBRONECTIN; GELATINASE A; HYDROGEN PEROXIDE; LATANOPROST; MESSENGER RNA; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; TRAVOPROST; AMIDE; ANTIHYPERTENSIVE AGENT; CLOPROSTENOL; DRUG DERIVATIVE; OXIDIZING AGENT; PROSTAGLANDIN F;

ADULT; ARTICLE; CELL DEATH; CELL LOSS; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; OPEN ANGLE GLAUCOMA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRABECULAR MESHWORK; APOPTOSIS; BIOSYNTHESIS; CADAVER; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETICS; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ADULT; AMIDES; ANTIHYPERTENSIVE AGENTS; APOPTOSIS; CADAVER; CELLS, CULTURED; CLOPROSTENOL; FIBRONECTINS; GENE EXPRESSION; GLAUCOMA, OPEN-ANGLE; HUMANS; HYDROGEN PEROXIDE; INTRAOCULAR PRESSURE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; OCULAR HYPERTENSION; OXIDANTS; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PROSTAGLANDINS F, SYNTHETIC; PROSTAGLANDINS, SYNTHETIC; RNA, MESSENGER; TRABECULAR MESHWORK;

EID: 56149119566     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-0984     Document Type: Article

References (57)

1. Lütjen-Drecoll E. Morphological changes in glaucomatous eyes and the role of TGFbeta2 for the pathogenesis of the disease. Exp Eye Res. 2005;81:1-4. (Pubitemid 40840540)
2. Liton PB, Challa P, Stinnett S, Luna C, Epstein DL, Gonzalez P. Cellular senescence in the glaucomatous outflow pathway. Exp Gerontol. 2005;40:745-748. (Pubitemid 41265825)
3. Wiggs JL. Genetic etiologies of glaucoma. Arch Ophthalmol. 2007;125:30-37.
4. Grieshaber MC, Flammer J. Blood flow in glaucoma. Curr Opin Ophthalmol. 2005;16:79-83.
5. Harju M, Vesti E. Blood flow of the optic nerve head and peripapillary retina in exfoliation syndrome with unilateral glaucoma or ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 2001;239:271-277. (Pubitemid 32514994)
6. Izzotti A, Bagnis A, Sacca SC. The role of oxidative stress in glaucoma. Mutat Res. 2006;612:105-114.
7. Abu-Amero KK, Morales J, Bosley TM. Mitochondrial abnormalities in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2006;47:2533-2541. (Pubitemid 351639838)
8. Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy SF. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol. 2004;137:62-69. (Pubitemid 38045188)
9. Sacca SC, Pascotto A, Camicione P, Capris P, Izzotti A. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol. 2005;123:458-463. (Pubitemid 40489915)
10. Sacca SC, Izzotti A, Rossi P, Traverso C. Glaucomatous outflow pathway and oxidative stress. Exp Eye Res. 2007;84:389-399. (Pubitemid 46210055)
11. Temple MD, Perrone GG, Dawes IW. Complex cellular responses to reactive oxygen species. Trends Cell Biol. 2005;15:319-326. (Pubitemid 40805328)
12. Dumont P, Burton M, Chen QM, et al. Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblast. Free Radic Biol Med. 2000;28:361-373. (Pubitemid 30110651)
13. Ding G, Franki N, Kapasi AA, Reddy K, Gibbons N, Singhal PC. Tubular cell senescence and expression of TGF-beta1 and p21(WAF1/CIP1) in tubulointerstitial fibrosis of aging rats. Exp Mol Pathol. 2001;70:43-53. (Pubitemid 34412202)
14. Zhang X, Li J, Sejas DP, Pang Q. Hypoxia-reoxygenation induces premature senescence in FA bone marrow hematopoietic cells. Blood. 2005;106:75-85. (Pubitemid 40967177)
15. Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev. 2005;85:1-31.
16. Minamino T, Miyauchi H, Yoshida T, Tateno K, Komuro I. The role of vascular cell senescence in atherosclerosis: antisenescence as a novel therapeutic strategy for vascular aging. Curr Vasc Pharmacol. 2004;2:141-148. (Pubitemid 38855022)
17. Stoneman VE, Bennett MR. Role of apoptosis in atherosclerosis and its therapeutic implications. Clin Sci (Lond). 2004;107:343-354. (Pubitemid 39389301)
18. Feher J, Kovacs I, Artico M, Cavallotti C, Papale A, Balacco Gabrieli C. Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration. Neurobiol Aging. 2006;27:983-993. (Pubitemid 44262273)
19. Roth F, Bindewald A, Holz FG. Key pathophysiologic pathways in age-related macular disease. Graefes Arch Clin Exp Ophthalmol. 2004;242:710-716. (Pubitemid 39242849)
20. Alvarado MC, Juster R. Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals. Ophthalmology. 1984;91:564-579. (Pubitemid 14120061)
21. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417-1436.
22. Guenoun JM, Baudoin C, Rat P, Pauly A, Warnet JM, Brignole-Baudoin F. In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci. 2005;46:4594-4599. (Pubitemid 44264559)
23. Camras CB, United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month, masked, multicenter trial in the United States. Ophthalmology. 1996;103:138-147.
24. Chew PT, Aung T, Aquino MV, Rojanapongpun P; EXACT Study Group. Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma. Ophthalmology. 2004;111:427-434. (Pubitemid 38293094)
25. Sihota R, Saxena R, Agarwal HC, Gulati V. Crossover comparison of timolol and latanoprost in chronic primary angle-closure glaucoma. Arch Ophthalmol. 2004;122:185-189. (Pubitemid 38176484)
26. Parrish RK, Palmberg P, Sheu WP; XLT Study Group. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol. 2003;135:688-703. (Pubitemid 36457976)
27. Hamard P, Blondin C, Debbasch C, Warnet JM, Baudouin C, Brignole F. In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells. Graefes Arch Clin Exp Ophthalmol. 2003;241:1037-1043. (Pubitemid 38028900)
28. Siegner A, May CA, Welge-Lüssen U, Bloemendal H, Lütjen-Drecoll E. αB-crystallin in the primate ciliary muscle and trabecular meshwork. Eur J Cell Biol. 1996;71:165-169. (Pubitemid 26348472)
29. Welge-Lüssen U, Eichhorn M, Bleomendal H, Lütjen-Drecoll E. Classification of human scleral spur cells in monolayer culture. Eur J Cell Biol. 1998;75:78-84. (Pubitemid 28080651)
30. Welge-Lüssen U, May CA, Eichhorn M, Bloemendal H, Lütjen-Drecoll E. αB-crystallin in the trabecular meshwork is inducible by transforming growth factor-beta. Invest Ophthalmol Vis Sci. 1999;40:2235-2241. (Pubitemid 29418377)
31. Welge-Lüssen U, May CA, Lütjen-Drecoll E. Induction of tissue transglutaminase in the trabecular meshwork by TGF-beta1 and TGF-beta2. Invest Ophthalmol Vis Sci. 2000;41:2229-2238. (Pubitemid 30450997)
32. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995;92:9363-9367.
33. Tamm ER, Russell P, Piatigorsky J. Development of characterization of a immortal and differentiated murine trabecular meshwork cell line. Invest Ophthalmol Vis Sci. 1999;40:1392-1403. (Pubitemid 29252330)
34. Alge CS, Priglinger SG, Neubauer AS, et al. Retinal pigment epithelium is protected against apoptosis by αB-crystallin. Invest Ophthalmol Vis Sci. 2002;43:3575-3582. (Pubitemid 35334367)
35. Maher P, Hanneken A. Flavonoids protect retinal ganglion cells from oxidative stress-induced death. Invest Ophthalmol Vis Sci. 2005;46:4796-4803. (Pubitemid 44264586)
36. Johnson DH, Richardson TM, Epstein DL. Trabecular meshwork recovery after phagocytic challenge. Curr Eye Res. 1989;8:1121-1130.
37. Zhou L, Li Y, Yue BY. Alteration of cytoskeletal structure, integrin distribution, and migratory activity by phagocytic challenge in cells from an ocular tissue: the trabecular meshwork. In Vitro Cell Dev Biol Anim. 1999;35:144-149. (Pubitemid 29136079)
38. Grierson I. What is open angle glaucoma? Eye. 1987;1:15-28. (Pubitemid 17134430)
39. Rohen JW, Lütjen-Drecoll E, Flugel C, Meyer M, Grierson I. Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma. Exp Eye Res. 1993;56:683-692. (Pubitemid 23183825)
40. Park SK, Kim J, Seomun Y, et al. Hydrogen peroxide is a novel inducer of connective tissue growth factor. Biochem Biophys Res Commun. 2001;284:966-971. (Pubitemid 32924742)
41. Iglesias-De La Cruz MC, Ruiz-Torres P, Alcami J, et al. Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int. 2001;59:87-95. (Pubitemid 32055217)
42. Babizhayev MA, Brodskaya MW. Fibronectin detection in drainage outflow system of human eyes in ageing and progression of open-angle glaucoma. Mech Ageing Dev. 1989;47:145-157.
43. Rohen JW, Witmer R. Electron microscopic studies on the trabecular meshwork in glaucoma simplex. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1972;183:251-266.
44. Acott TS. Trabecular extracellular matrix regulation. In: Drance SM, Van Buskirk EM, Neufeld AH, eds. Pharmacology of Glaucoma. Baltimore, MD: Williams & Wilkins; 1992:125-157.
45. John M, Jaworski C, Chen Z, et al. Matrix metalloproteinases are down-regulated in rat lenses exposed to oxidative stress. Exp Eye Res. 2004;79:839-846. (Pubitemid 40092275)
46. Liton PB, Challa P, Stinnett S, Luna C, Epstein DL, Gonzalez P. Cellular senescence in the glaucomatous outflow pathway. Exp Gerontol. 2005;40:745-748. (Pubitemid 41265825)
47. Toussaint O, Medrano EE, von Zglinicki T. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp Gerontol. 2000;35:927-945. (Pubitemid 30838466)
48. Frippiat C, Chen QM, Zdanov S, Magalhaes JP, Remacle J, Toussaint O. Subcytotoxic H2O2 stress triggers a release of transforming growth factor-beta1, which induces biomarkers of cellular senescence of human diploid fibroblasts. J Biol Chem. 2001;276(4):2531-2537. (Pubitemid 37376625)
49. Debacq-Chainiaux F, Borlon C, Pascal T, et al. Repeated exposure of human skin fibroblasts to UVB at subcytotoxic level triggers premature senescence through the TGF-beta1 signaling pathway. J Cell Sci. 2005;118:743-758. (Pubitemid 40372583)
50. Gurjala AN, Liu WR, Mogford JE, Procaccini PS, Mustoe TA. Age-dependent response of primary human dermal fibroblasts to oxidative stress: cell survival, pro-survival kinases, and entrance into cellular senescence. Wound Repair Regen. 2005;13(6):565-575.
51. Debbasch C, Brignole F, Pisella PJ, Warnet JM, Rat P, Baudouin C. Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci. 2001;42:642-652. (Pubitemid 32206903)
52. Oh DJ, Martin JL, Williams AJ, Russell P, Birk DE, Rhee DJ. Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2006;47:3887-13395 (Pubitemid 46044304)
53. Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM, Brignole-Baudouin F. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci. 2005;46:2444-2450. (Pubitemid 43119492)
54. Kim EJ, Kwon KJ, Park JY, Lee SH, Moon CH, Baik EJ. Neuroprotective effects of prostaglandin E2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation. J Neurosci Res. 2002;70:97-107.
55. Towndrow KM, Mertens JJ, Jeong JK, Weber TJ, Monks TJ, Lau SS. Stress- and growth-related gene expression are independent of chemical-induced prostaglandin E(2) synthesis in renal epithelial cells. Chem Res Toxicol. 2000;13:111-117.
56. Towndrow KM, Jia Z, Lo HH, Person MD, Monks TJ, Lau SS. 11-Deoxy,16,16-dimethyl prostaglandin E2 induces specific proteins in association with its ability to protect against oxidative stress. Chem Res Toxicol. 2003;16:312-319. (Pubitemid 36373696)
57. Thieme H, Schimmat C, Muenzer G, et al. Endothelin antagonism: effects of FP receptor agonists prostaglandin F2α and fluprostenol on trabecular meshwork contractility. Invest Ophthalmol Vis Sci. 2006;47:938-945. (Pubitemid 46768325)